Seguimos creciendo para Brindar el mejor servicio

Breast Cancer

HER-2 Testing and Trastuzumab Therapy for Metastatic Breast Cancer: A Cost-Effectiveness Analysis

Activity and Safety of the Antiestrogen EM-800, the Orally Active Precursor of Acolbifene, in Tamoxifen-Resistant Breast Cancer

COMMENTS AND CONTROVERSIES

Physician-Nurse Collaboration in Research in the 21st Century

Noticias del día

Diagnosis in oncology

Difficult Diagnostic and Therapeutic Cases: CASE 1. True Thymic Hyperplasia in a Patient Treated for T-Cell Lymphoma

Difficult Diagnostic and Therapeutic Cases: CASE 2. Thymoma and Tumor Lysis Syndrome in an Adolescent

Difficult Diagnostic and Therapeutic Cases: CASE 3. Presentation of Prostate Cancer With Cervical Adenopathy

Noticias del día

Editorial

Combining the Anti-EGFR Agent Gefitinib With Chemotherapy in Non–Small-Cell Lung Cancer: How Do We Go From INTACT to Impact?

Tumor Immunity in Small-Cell Lung Cancer

Hypofractionated Radiotherapy for Advanced Non-Small-Cell Lung Cancer: Is the LINAC Half Full?

Cardiovascular Trials in Long-Term Survivors of Childhood Cancer

Seguimos creciendo para Brindar el mejor servicio

Gastrointestinal Cancer

Time Course of Tumor Metabolic Activity During Chemoradiotherapy of Esophageal Squamous Cell Carcinoma and Response to Treatment

Genitourinary Cancer

Randomized Phase II Study of Multiple Dose Levels of CCI-779, a Novel Mammalian Target of Rapamycin Kinase Inhibitor, in Patients With Advanced Refractory Renal Cell Carcinoma

Gynecologic Cancer

Pelvic Irradiation With Concurrent Chemotherapy Versus Pelvic and Para-Aortic Irradiation for High-Risk Cervical Cancer: An Update of Radiation Therapy Oncology Group Trial (RTOG) 90-02

Predictors of Sexual Functioning in Ovarian Cancer Patients

Seguimos creciendo para Brindar el mejor servicio

Lung cancer

Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1

Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2

Hu and Voltage-Gated Calcium Channel (VGCC) Antibodies Related to the Prognosis of Small-Cell Lung Cancer

Hypofractionated Palliative Radiotherapy (17 Gy per two fractions) in Advanced Non–Small-Cell Lung Carcinoma Is Comparable to Standard Fractionation for Symptom Control and Survival: A National Phase III Trial

Prognostic Model of Pulmonary Adenocarcinoma by Expression Profiling of Eight Genes As Determined by Quantitative Real-Time Reverse Transcriptase Polymerase Chain Reaction

Seguimos creciendo para Brindar el mejor servicio

Neurooncology

Primary Chemotherapy for Intracranial Nongerminomatous Germ Cell Tumors: Results of the Second International CNS Germ Cell Study Group Protocol

Pediatric Oncology

Enalapril to Prevent Cardiac Function Decline in Long-Term Survivors of Pediatric Cancer Exposed to Anthracyclines

Phase I and Pharmacokinetic Study of Topotecan Administered Orally Once Daily for 5 Days for 2 Consecutive Weeks to Pediatric Patients With Refractory Solid Tumors

Clinical and Outcome Characteristics of Children With Adrenocortical Tumors: A Report From the International Pediatric Adrenocortical Tumor Registry

Seguimos creciendo para Brindar el mejor servicio

Phase I and Clinical Pharmacology

Pharmacokinetics and Pharmacodynamics of Imatinib in a Phase I Trial With Chronic Myeloid Leukemia Patients

Review Articles

Short-Term Impact of Cancer Prevention and Screening Activities on Quality of Life

Sarcoma

Phase II Study of Ecteinascidin-743 in Advanced Pretreated Soft Tissue Sarcoma Patients

Noticias del día

Supportive Care and Quality of Life

Prevalence and Predictors of Psychological Distress Among Women With Ovarian Cancer

Lamivudine for the Prevention of Hepatitis B Virus Reactivation in Hepatitis B s-Antigen Seropositive Cancer Patients Undergoing Cytotoxic Chemotherapy

Buscador

Copyright © Dr. Mario I. Cámera .:. Powered by ForamenAlojado en ...